Redmile as of March 31, 2013
Portfolio Holdings for Redmile
Redmile holds 50 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares Russell 2000 Index (IWM) | 12.1 | $66M | 700k | 94.43 | |
| Onyx Pharmaceuticals | 6.6 | $36M | 402k | 88.86 | |
| Gilead Sciences (GILD) | 6.5 | $36M | 727k | 48.94 | |
| Align Technology (ALGN) | 5.0 | $27M | 807k | 33.51 | |
| Universal Health Services (UHS) | 4.6 | $25M | 389k | 63.87 | |
| Array BioPharma | 4.3 | $23M | 4.7M | 4.91 | |
| Pfizer (PFE) | 3.5 | $19M | 667k | 28.86 | |
| Salix Pharmaceuticals | 3.5 | $19M | 374k | 51.18 | |
| Puma Biotechnology (PBYI) | 3.3 | $18M | 535k | 33.39 | |
| Insulet Corporation (PODD) | 3.2 | $17M | 674k | 25.86 | |
| HeartWare International | 3.1 | $17M | 189k | 88.40 | |
| Ariad Pharmaceuticals | 2.7 | $15M | 817k | 18.08 | |
| Clovis Oncology | 2.6 | $14M | 497k | 28.67 | |
| Conceptus | 2.6 | $14M | 582k | 24.15 | |
| Hca Holdings (HCA) | 2.4 | $13M | 327k | 40.63 | |
| Sirona Dental Systems | 2.4 | $13M | 179k | 73.73 | |
| AstraZeneca (AZN) | 2.3 | $13M | 252k | 49.98 | |
| Grifols S A Sponsored Adr R (GRFS) | 2.3 | $12M | 426k | 29.01 | |
| Vanguard Health Systems | 2.0 | $11M | 734k | 14.87 | |
| Brookdale Senior Living (BKD) | 1.9 | $10M | 375k | 27.88 | |
| Impax Laboratories | 1.9 | $10M | 655k | 15.44 | |
| Dynavax Technologies Corporation | 1.8 | $10M | 4.5M | 2.22 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $9.6M | 791k | 12.15 | |
| Optimer Pharmaceuticals | 1.6 | $9.0M | 755k | 11.90 | |
| Orexigen Therapeutics | 1.6 | $8.4M | 1.3M | 6.26 | |
| Globus Med Inc cl a (GMED) | 1.5 | $8.0M | 545k | 14.68 | |
| Cyberonics | 1.4 | $7.8M | 166k | 46.80 | |
| Capital Senior Living Corporation | 1.2 | $6.8M | 258k | 26.43 | |
| Cerus Corporation (CERS) | 1.2 | $6.7M | 1.5M | 4.42 | |
| Cepheid | 1.2 | $6.3M | 165k | 38.37 | |
| Amicus Therapeutics (FOLD) | 1.2 | $6.3M | 2.0M | 3.17 | |
| BioSpecifics Technologies | 1.0 | $5.3M | 312k | 17.05 | |
| Trius Therapeutics | 1.0 | $5.3M | 778k | 6.84 | |
| Exelixis Inc cnv | 0.9 | $5.0M | 5.0M | 0.99 | |
| ArthroCare Corporation | 0.8 | $4.2M | 122k | 34.76 | |
| NuVasive | 0.7 | $3.5M | 165k | 21.31 | |
| Cyclacel Pharmaceuticals | 0.6 | $3.2M | 578k | 5.59 | |
| Cardinal Health (CAH) | 0.5 | $2.7M | 66k | 41.62 | |
| Kythera Biopharmaceuticals I | 0.5 | $2.6M | 108k | 24.36 | |
| Greenway Medical Technology | 0.5 | $2.5M | 160k | 15.90 | |
| Given Imaging | 0.1 | $409k | 25k | 16.36 | |
| Accuray Inc Del note 3.750% 8/0 | 0.1 | $445k | 500k | 0.89 | |
| UnitedHealth (UNH) | 0.1 | $286k | 5.0k | 57.20 | |
| iShares Dow Jones US Health Care (IHF) | 0.1 | $284k | 3.7k | 76.76 | |
| Market Vectors Etf Tr pharmaceutical | 0.1 | $293k | 6.5k | 45.08 | |
| Hologic (HOLX) | 0.0 | $219k | 9.7k | 22.58 | |
| Health Management Associates | 0.0 | $156k | 12k | 12.87 | |
| Momenta Pharmaceuticals | 0.0 | $179k | 13k | 13.36 | |
| Exelixis (EXEL) | 0.0 | $103k | 22k | 4.62 | |
| Idenix Pharmaceuticals | 0.0 | $107k | 30k | 3.54 |
